Exclusive Online Content
Drug R&D Costs: $1.7 Billion & Rising
The significant costs of developing new, life-saving drugs and treatments has reached over $1.7 billion per drug over a span of 10-12 years. The mounting…
Melanoma Treatment Market Value to More Than Quadruple to $5.64 Billion
The global treatment market for melanoma will expand more than four-fold in value from $1.34 billion in 2013 to reach an estimated $5.64 billion by…
Top Mid-Cap Biotech Companies Increased Revenues to $26.5 Billion in 2014
The combined total revenues for the peer group of 35 mid-cap biotech companies increased from $24.8 billion in 2013 to $26.5 billion in 2014, representing…
Aptar Pharma Twister® Chosen for Asthma Therapy
Louveciennes, France - Aptar Pharma, a global solution provider of innovative and proven aerosol, injection and spray delivery systems for biotech, healthcare and pharma products…
TPG Completes Acquisition of Aptalis Pharmaceutical Technologies, Company Renamed Adare
BRIDGEWATER, New Jersey and FORT WORTH, Texas – Aptalis Pharmaceutical Technologies recently announced that its divestiture from Actavis plc to TPG, a global…
Development & Commercialization of Antibacterial Drugs to Speed Up
The growing threat posed by multi-drug resistant gram-negative organisms (MDR-GNBs) is lending a sense of urgency to the development of antibacterial drugs worldwide. Upcoming regulatory…
US Rheumatoid Arthritis Treatment Market Value to Reach $9.3 Billion
The US treatment market for Rheumatoid Arthritis (RA) is set to increase in value from $6.4 billion in 2013 to $9.3 billion by 2020, representing…
Confluence Pharmaceuticals Signs Co-Development & Marketing Agreement
Confluence Pharmaceuticals and AOP Orphan Pharmaceuticals AG recently announced they have signed a definitive agreement to co-develop and market Confluence’s lead asset, a product for the…
Identification of Foreign Particulate Matter Using Automated Raman & Automated SEM-EDS
By: Angela Flowers, Emily Landsperger, Rebekah Byrne, and Dave Exline, Gateway Analytical Foreign particulate matter in drug products is a common problem in the…
Germany’s Pharmaceutical Market Value Will Crawl to $65 Billion
While Germany is the leading pharmaceutical market in Europe, valued at $58.6 billion in 2014, the sector will expand at a modest Compound Annual Growth…
The $700-Billion Connected Life Market That Will Drive Change & Growth
We are living a connected life in a connected world. Our smartphone is our gateway to the world, and very soon, we will be able…
From Volume to Value
By: Alan Shortall, Unilife Chairman & CEO As healthcare markets continue to shift to a model based on value-based outcomes, Bluetooth-enabled smart medical technologies…
New Mechanism for Engineering Genetic Traits Governed by Multiple Genes Paves Way for Various Advances
When it comes to gene expression, scientists have so far studied one single gene at a time. A new approach developed by Harvard geneticist George…
US Asthma Treatment Market Value to Hit $14 Billion
The US treatment market for asthma will rise in value from $11.7 billion in 2013 to an estimated $14 billion by 2020, representing a Compound…
Xcelience to Expand Operations, Will Create 100 New Jobs, Capital Investment of More Than $9 Million
TAMPA, Fla. – March 13, 2014 - Today, Governor Rick Scott announced the expansion of Xcelience, an international contract development and manufacturing organization (CDMO) servicing…
Opportunities Galore in Biosimilars Industry
BCC Research reveals in its new report on biosimilars, the development of biotherapeutics through the use of advanced technology has facilitated the management of disease…
Stents Market to Reach More Than $10.6 Billion in 2019
BCC Research reveals in its new report on stents there has recently been several innovations and developments expected to influence the market, particularly with bioabsorbable…
Combination Product Technology to Reach $31 Billion; Sector Attracting Massive Developmental Companies
BCC Research reveals in its new report on drug-device combination products, developments in cell-based therapeutics, progenitor cell exploitation, growth factor delivery, and advanced formulation strategies…
Patheon Adds Complex Solubility Expertise With Acquisition of Agere
Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, has reached a definitive agreement to acquire…
Patheon Expands Comprehensive API Services With Major Acquisition
Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, recently announced it has reached a definitive…
